2016

Godefroy O, Martinaud O, Verny M, Mosca C, Lenoir H, Bretault E, Devendeville A, Diouf M, Pere JJ, Bakchine S,  Delabrousse-Mayoux JP, Roussel M. on the behalf of the GREFEX and REFLEX study groups. Crossvalidation of a shortened battery for the assessment of dysexecutive disorders in Alzheimer’s disease. Alzheimer Dis Assoc Disord. 2016; 30: 140-4.

Puy L, Lamy C, Arnoux A, Zerbib Y, Constans JM, Godefroy O. Des anomalies bithalamiques. Rev Med Interne. 2016 Feb 5. pii: S0248-8663(15)01107-8.

Godefroy O, Bakchine S, Verny M, Delabrousse-Mayoux JP, Roussel M, Pere JJ. Characteristics of Alzheimer's Disease Patients with Severe Executive Disorders. J Alzheimers Dis. 2016; 51: 815-25.

Andruita D, Moullart V, Schraen S, Devendeville A, Meyer ME, Godefroy O; Alzheimer’s Disease Neuroimaging. What are the Most Frequently Impaired Markers of Neurodegeneration in ADNI Subjects? J Alzheimers Dis. 2016; 51: 793-800.

Roussel M, Martinaud O, Hénon H, Vercelletto M, Bindschadler C, Joseph PA, Robert P, Labauge P, Godefroy O; GREFEX study group. The Behavioral and Cognitive Executive Disorders of Stroke: The GREFEX Study. PLoS One. 2016; 11: e0147602.

Narme P, Roussel M, Mouras H, Krystkowiak P, Godefroy O. Does impaired socioemotional functioning account for behavioral dysexecutive disorders? Evidence from a transnosological study. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2016:1-14;

Boone M, Roussel M, Chauffert B, Le Gars D, Godefroy O. Prevalence and profile of cognitive impairment in adult glioma: a sensitivity analysis. J Neurooncol. 2016

Kouidrat Y, Amad A, Renard N, Corneille F, Lalau JD, Loas G. [Management of eating disorders in schizophrenia]. Soins Psychiatr. 2016 May-Jun;37(304):39-43.

Batselé E, Denollet J, Lussier A, Loas G, Vanden Eynde S, Van de Borne P, Fantini-Hauwel C. Type D personality: Application of DS14 French version ingeneral and clinical populations. J Health Psychol. 2016 Jan  pii:13591053156244

Nicolas G, Pottier C, Charbonnier C, Guyant-Maréchal L, Le Ber I, Pariente J, Labauge P, Ayrignac X, Defebvre L, Maltête D, Martinaud O, Lefaucheur R, Guillin O, Wallon D, Chaumette B, Rondepierre P,

Nicolas G, Pottier C, Maltête D, Coutant S, Rovelet-Lecrux A, Legallic S, Rousseau S, Vaschalde Y, Guyant-Maréchal L, Augustin J, Martinaud O, Defebvre L, Krystkowiak P, Pariente J, Clanet M,

Bucchioni G, Fossataro C, Cavallo A, Mouras H, Neppi-Modona M, Garbarini F. Empathy or Ownership? Evidence from Corticospinal Modulation during Pain Observation. J Cogn Neurosci. 2016 Jul 5:1-12.

2015

Mouras H, Lelard T, Ahmaidi S, Godefroy O, Krystkowiak P. Freezing behavior as a response to sexual visual stimuli as demonstrated by posturography. PLoS One. 2015;10: e0127097.

Bucchioni G, Lelard T, Ahmaidi S, Godefroy O, Krystkowiak P, Mouras H. Do we feel the same empathy for loved and hated peers? PLoS One. 2015; 10(5):e0125871.

Decourcelle A, Moulin S, Sibon I, Murao K, Ronzière T, Godefroy O, Poli M, Cordonnier C, Sagnier S, Lassalle V, Okada Y, Mas JL, Bordet R, Leys D. Influence of previous physical activity on the outcome of patients treated by thrombolytic therapy for stroke. J Neurol. 2015

Andriuta D, Tir M, Perin B, Merle PE, Bryer-Le Breton C, Charbonnier A, Constans JM, Godefroy O. Teaching NeuroImages: Epilepsia partialis continua revealing PML after allogenic stem cell transplantation. Neurology. 2015; 85: e53-4.

Azouvi P, Vallat-Azouvi C, Joseph PA, Meulemans T, Bertola C, Le Gall D, Bellmann A, Roussel M, Coyette F, Krier M, Franconie C, Bindschadler C, Diouf M, Godefroy O; GREFEX Study Group (Groupe de Réflexion sur lʼEvaluation des Fonctions Exécutives). Executive Functions Deficits After Severe Traumatic Brain Injury: The GREFEX Study. J Head Trauma Rehabil. 2015; 31 : E10-20.

Braun S, Rosseel Y, Kempenaers C, Loas G, Linkowski P. SELF-REPORT OF EMPATHY: A SHORTENED FRENCH ADAPTATION OF THE INTERPERSONAL REACTIVITY INDEX (IRI) USINGTWO LARGE BELGIAN SAMPLES. Psychol Rep. 2015 Dec;117(3):735- 53.

Loas G, Braun S, Linkowski P, Luminet O. DETERMINATION OF THE CUTOFF THRESHOLD ON THE BERMOND-VORST ALEXITHYMIA QUESTIONNAIRE-20 FORM B: A STUDY OF 560 YOUNGADULTS. Psychol Rep. 2015 Dec;117(3):754-

Depauw A, Loas G, Delhaye M. [Munchausen by proxy syndrome]. Rev Med Brux. 2015 May-Jun;36(3):152-7.

Godart N, Radon L, Curt F, Duclos J, Perdereau F, Lang F, Venisse JL, Halfon O, Bizouard P, Loas G, Corcos M, Jeammet P, Flament MF. Mood disorders in eating disorder patients: Prevalence and chronology of ONSET. J Affect Disord. 2015 Oct . 1;185:115-22.

Kouidrat Y, Amad A, Arai M, Miyashita M, Lalau JD, Loas G, Itokawa M. Advanced glycation end products and schizophrenia: A systematic review. J Psychiatr Res. 2015 Jul-Aug;66-67:112-7

Lussier A, Loas G. RELATIONSHIP BETWEEN TYPE D PERSONALITY AND ANHEDONIA: A DIMENSIONAL STUDY OF UNIVERSITY STUDENTS. Psychol Rep. 2015 Jun;116(3):855-60.

Gignon M, Havet E, Ammirati C, Traullé S, Manaouil C, Balcaen T, Loas G, Dubois G, Ganry O. Alcohol, cigarette, and illegal substance consumption among medical students: a cross-sectional survey. Workplace Health Saf. 2015 Feb;63(2):54- 63.

Loas G, Baelde O, Verrier A. Relationship between alexithymia and dependent personality disorder: a dimensional analysis. Psychiatry Res. 2015 Feb 28;225(3):484-8.

Monestès JL, Vavasseur-Desperriers J, Villatte M, Denizot L, Loas G, Rusinek  S. [Influence of resistance to voices on depression]. Encephale. 2015 Feb;41(1):25-31.

Schramm C, Katsahian S, Youssov K, Démonet JF, Krystkowiak P, Supiot F, Verny C, Cleret de Langavant L, Bachoud-Lévi AC; European Huntington's Disease Initiative Study Group and the Multicentre Intracerebral Grafting in Huntington's Disease Group. How to Capitalize on the Retest Effect in Future Trials on Huntington's Disease. PLoS One. 2015 Dec 29;10(12):e0145842

Cleret de Langavant L, Sudraud S, Verny C, Krystkowiak P, Simonin C, Damier P, Demonet JF, Supiot F, Rialland A, Schmitz D, Maison P, Youssov K, Bachoud-Lévi AC. Longitudinal study of informed consent in innovative therapy research: experience and provisional recommendations from a multicenter trial of intracerebral grafting. PLoS One. 2015 May 26;10(5):e0128209.

Moreau C, Meguig S, Corvol JC, Labreuche J, Vasseur F, Duhamel A, Delval A, Bardyn T, Devedjian JC, Rouaix N, Petyt G, Brefel-Courbon C, Ory-Magne F, Guehl D, Eusebio A, Fraix V, Saulnier PJ, Lagha-Boukbiza O, Durif F, Faighel M, Giordana C, Drapier S, Maltête D, Tranchant C, Houeto JL, Debû B, Azulay JP, Tison F, Destée A, Vidailhet M, Rascol O, Dujardin K, Defebvre L, Bordet R, Sablonnière B, Devos D; Parkgait-II Study Group. Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson's disease. Brain. 2015 May;138(Pt 5):1271-83.

2014

Godefroy O, Gibbons L, Diouf M, Nyenhuis D, Roussel M, Black S, Bugnicourt JM; GREFEX study group. Validation of an integrated method for determining cognitive ability: Implications for routine assessments and clinical trials. Cortex. 2014; 54: 51-62.

Loas G, Duru C, Godefroy O, Krystkowiak P. Hedonic deficits in Parkinson's disease: is consummatory anhedonia specific? Front Neurol. 2014; 5: 24.

Murao K, Leys D, Jacquin A, Kitazono T, Bordet R, Béjot Y, Kimura K, Godefroy O, Wakisaka Y, Moulin S, Ago T, Sibon I, Bombois S, Mas JL, Hénon H, Pasquier F, Giroud M, Cordonnier C, Okada Y; On behalf of the OPHELIE-COG investigators. Thrombolytic therapy for stroke in patients with preexisting cognitive impairment. Neurology. 2014; 82: 2048-54.

Godefroy O, Martinaud O, Verny M, Mosca C, Lenoir H, Bretault E Roussel M and GREFEX study group. The dysexecutive syndrome of Alzheimer’s disease. The GREFEX study.J Alzheimer Dis. 2014; 42: 1203-8.

Lelard T, Krystkowiak P, Montalan B, Longin E, Bucchioni G, Ahmaidi S, Godefroy O, Mouras H. Influence of postural threat on postural responses to aversive visual stimuli. Behav Brain Res. 2014; 266: 137-45.

Kouidrat Y, Amad A, Lalau JD, Loas G. Eating disorders in schizophrenia: implications for research and management. Schizophr Res Treatment. 2014;2014:791573.

Loas G, Verrier A, Monestes JL. Relationship between anticipatory, consummatory anhedonia and disorganization in schizotypy. BMC Psychiatry. 2014 Aug 1;14:2.

Terrien S, Stefaniak N, Blondel M, Mouras H, Morvan Y, Besche-Richard C. Theory of mind and hypomanic traits in general population. Psychiatry Res. 2014 Mar 30;215(3):694-9.

Lefranc M, Derrey S, Merle P, Tir M, Constans JM, Montpellier D, Macron JM, Le Gars D, Peltier J, Baledentt O, Krystkowiak P. High-resolution 3-dimensional T2*-weighted angiography (HR 3-D SWAN): an optimized 3-T magnetic resonance imaging sequence for targeting the subthalamic nucleus. Neurosurgery. 2014 Jun;74(6):615-26; discussion 627.

Lefranc M, Manto M, Merle P, Tir M, Montpellier D, Constant JM, Le Gars D, Macron JM, Krystkowiak P. Targeting the red nucleus for cerebellar tremor. Cerebellum. 2014 Jun;13(3):372-7.

Devos D, Moreau C, Maltête D, Lefaucheur R, Kreisler A, Eusebio A, Defer G, Ouk T, Azulay JP, Krystkowiak P, Witjas T, Delliaux M, Destée A, Duhamel A, Bordet R, Defebvre L, Dujardin K. Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial. J Neurol Neurosurg Psychiatry. 2014 Jun;85(6):668-74.

 

2013

Leroy M, Loas G, Perez-Diaz F. Is impulsivity a risk factor of clinical events in acute coronary syndrome? A three-year follow-up study. Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jan 10;40:149- 52

Loas G, Pham-Scottez A, Cailhol L, Perez-Diaz F, Corcos M, Speranza M. Axis II comorbidity of borderline personality disorder in adolescents. Psychopathology. 2013;46(3):172-5.

Labauge P, Ayrignac X, Lefaucheur R, Le Ber I, Frébourg T, Hannequin D, Campion D. Mutation of the PDGFRB gene as a cause of idiopathic basal ganglia calcification. Neurology. 2013 Jan 8;80(2):181-7.

Garcia PY, Roussel M, Lamy C, Canaple S, Bugnicourt JM, Peltier J, Loas G, Deramond H, Godefroy O. Cognitive impairment and dementia following intracerebral hemorrhage: a cross-sectional study of a university hospital-based series. J Stroke Cerebrovasc Dis. 2013; 22: 80-6

Bugnicourt JM, Guegan-Massardier E, Roussel M, Martinaud O, Canaple S, Triquenot-Bagan A, Wallon D, Lamy C, Leclercq C, Hannequin D, Godefroy O. Cognitive impairment after cerebral venous thrombosis: a two-center study. J Neurol. 2013; 260: 1324-31.

Bugnicourt JM, Godefroy O, Chillon JM, Choukroun G, Massy ZA. Cognitive Disorders and Dementia in CKD: The Neglected Kidney-Brain Axis.J Am Soc Nephrol. 2013; 24: 353-63.

Narme P, Mouras H, Roussel M, Duru C, Krystkowiak P, Godefroy O. Emotional and cognitive social processes are impaired in Parkinson's disease and are related to behavioral disorders. Neuropsychology. 2013; 27: 182-92.

Oprisiu R, Fournier A, Achard JM, Black SE, Serot JM, Godefroy O. Association between angiotensin receptor blockers and better cognitive outcome: urgent need for a randomized trial. JAMA Neurol. 2013; 70: 413-4. (lettre).

Bugnicourt JM, Canaple S, Lamy C, Deramond H, Godefroy O. T2*-weighted findings in prolonged acute migraine aura. Chin Med J (Engl). 2013; 126: 4000.

Bugnicourt JM, Tchouata-Ngandjouc L, Beugre K, Chillon JM, Godefroy O. A comparison of stroke patients' characteristics between a sub-Saharan Africa population (Abidjan) and a French stroke unit (Amiens): An observational study. Rev Neurol 2013; 169: 258-65.

Lelard T, Montalan B, Morel MF, Krystkowiak P, Ahmaidi S, Godefroy O, Mouras H. Postural correlates with painful situations. Front Hum Neurosci. 2013;7:4.

Khedr AA, Canaple S, Monet P, Godefroy O, Bugnicourt JM. MRI and magnetic resonance angiography findings in patients with multiple sclerosis mimicked by stroke. J Clin Neurosci. 2013; 20: 1163-4.

Simonin C, Duru C, Salleron J, Hincker P, Charles P, Delval A, Youssov K, Burnouf S, Azulay JP, Verny C, Scherer C, Tranchant C, Goizet C, Debruxelles S, Defebvre L, Sablonnière B, Romon-Rousseaux M, Buée L, Destée A, Godefroy O, Dürr A, Landwehrmeyer B; REGISTRY Study of the European Huntington's Disease Network, Bachoud-Levi AC, Richard F, Blum D, Krystkowiak P; On behalf the Huntington French Speaking Network. Association between caffeine intake and age at onset in Huntington's disease. Neurobiol Dis. 2013; 58:179-82.

Narme P, Mouras H, Roussel M, Devendeville A, Godefroy O. Assessment of socioemotional processes facilitates the distinction between frontotemporal lobar degeneration and Alzheimer's disease. J Clin Exp Neuropsychol. 2013; 35: 728-44.

Hequette J, Narme P, Perin B, Godefroy O, Loas G. Loss of emotional responsiveness secondary to left amygdalohippocampectomy performed for the treatment of complex, drug-resistant partial epilepsy. J Neuropsychiatry Clin Neurosci. 2013 Summer; 25: E55-9.

Pour le comité d’organisation, Hannequin D, Amieva H, Dubois B, Godefroy O, Pasquier F. Dementia: new concepts, new goals. Rev Neurol 2013;169: 677-9.

Godefroy O; GRECOG-VASC study group, Leclercq C, Bugnicourt JM, Roussel M, Moroni C, Quaglino V, Beaunieux H, Taillia H, Nédélec-Ciceri C, Bonnin C, Thomas-Anterion C, Varvat J, Aboulafia-Brakha T, Assal F. Neuropsychological assessment and cerebral vascular disease: the new standards. Rev Neurol. 2013; 169: 779-85.

Loas G, Dimassi H, Monestes JL, Yon V. Criterion validity of the cognitive slippage and schizotypal ambivalence scales. Psychol Rep. 2013 Dec;113(3):930-4.

Kouidrat Y, Amad A, Desailloud R, Diouf M, Fertout E, Scoury D, Lalau JD, Loas G. Increased advanced glycation end-products (AGEs) assessed by skin autofluorescence in schizophrenia. J Psychiatr Res. 2013 Aug;47(8):1044-8.

Derache N, Fromager G, Schaeffer S, Krystkowiak P, Verny C, Jurici S, Sauvée M, Vérin M, Lebouvier T, Rouaud O, Thauvin-Robinet C, Rousseau S, Rovelet-Lecrux A, Frebourg T, Campion D, Hannequin D; French IBGC Study Group. Phenotypic spectrum of probable and genetically-confirmed idiopathic basal ganglia calcification. Brain. 2013 Nov;136(Pt 11):3395-407.

Metzger S, Walter C, Riess O, Roos RA, Nielsen JE, Craufurd D; REGISTRY Investigators of the European Huntington’s Disease Network, Nguyen HP. The V471A polymorphism in autophagy-related gene ATG7 modifies age at onset specifically in Italian Huntington disease patients. PLoS One. 2013 Jul 22;8(7):e68951.

Hubers AA, van Duijn E, Roos RA, Craufurd D, Rickards H, Bernhard Landwehrmeyer G, van der Mast RC, Giltay EJ; REGISTRY investigators of the European Huntington's Disease Network. Suicidal ideation in a European Huntington's disease population. J Affect Disord. 2013 Oct;151(1):248-58

2012

Fertout E, Scoury D, Lefebvre O, Kouidrat Y, Loas G. Anhedonia in Kraepelinian schizophrenia: a preliminary study. Psychol Rep. 2012 Dec;111(3):755- 60.

Loas G, Dimassi H, Yon V, Monestes JL. Subjective experiences in first-degree relatives of schizophrenic subjects. Psychol Rep. 2012 Oct;111(2):493-4.

Loas G, Defélice E. Absolute and relative short-term stability of interpersonal dependency in suicide attempters. J Nerv Ment Dis. 2012 Oct;200(10):904-7.

Loas G. Alexithymia and dependent personality disorder. Psychiatry Res. 2012 Apr 30;196(2-3):325-6; author reply 327-8.

Cubo E, González M, del Puerto I, de Yébenes JG, Arconada OF, Gabriel y Galán JM; European Huntington's Disease Initiative Study Group. Placebo effect characteristics observed in a single, international, longitudinal study in Huntington's disease. Mov Disord. 2012 Mar;27(3):439-42.

Loas G, Speranza M, Pham-Scottez A, Perez-Diaz F, Corcos M. Alexithymia in adolescents with borderline personality disorder. J Psychosom Res. 2012 Feb;72(2):147- 52.

Speranza M, Revah-Levy A, Giquel L, Loas G, Venisse JL, Jeammet P, Corcos M.  An investigation of Goodman's addictive disorder criteria in eating disorders. Eur Eat Disord Rev. 2012 May;20(3):182-9.

Godefroy O, Just A, Ghitu A, Leclercq C, Garcia PY, Lamy C, Canaple S, Bugnicourt JM. Rankin scale with revised Structured Interview. Int J Stroke 2012; 7: 183-4.

Chaumeil MM, Valette J, Baligand C, Brouillet E, Hantraye P, Bloch G, Gaura V, Rialland A, Krystkowiak P, Verny C, Damier P, Remy P, Bachoud-Levi AC, Carlier P, Lebon V. pH as a biomarker of neurodegeneration in Huntington's disease: a translational rodent-human MRS study. J Cereb Blood Flow Metab. 2012 May;32(5):771-9.

Estellon V, Mouras H. Sexual addiction: insights from psychoanalysis and functional neuroimaging. Socioaffect Neurosci Psychol. 2012 Jan 20;2:11814.

Godefroy O, Leclercq C, Roussel M, Moroni C, Quaglino V, Beaunieux H, Taillia H, Nédélec-Ciceri C, Bonnin C, Thomas-Anterion C, Varvat J, Aboulafia-Brakha T, Assal F, on the behalf of the Grecog-Vasc neuropsychological Committee. French adaptation of the Vascular Cognitive Impairment harmonization standards: the Grecog-Vasc study. Int J Stroke. 2012; 7: 362-3.

Guiraud V, Touzé E, Rouillon F, Godefroy O, Mas JL. Stressful life events as triggers of ischemic stroke: a case-crossover study. Int J Stroke. 2012.

Boone M, Chillon JM, Garcia PY, Canaple S, Lamy C, Godefroy O, Bugnicourt JM. NIHSS and acute complications after anterior and posterior circulation strokes. Ther Clin Risk Manag. 2012;8:87-93.

Durand-Birchenall J, Leclercq C, Daouk J, Monet P, Godefroy O, Bugnicourt JM. Attenuation of brain white matter lesions after lacunar stroke. Int J Prev Med. 2012; 3: 134-8.

Bugnicourt JM, Monet-Desblache P, Deramond H, Godefroy O. The "carotid CT crescent" sign. Clin Neurol Neurosurg. 2012 ;114: 803-5

Peltier J, Roussel M, Gerard Y, Lassonde M, Deramond H, Le Gars D, De Beaumont L, Godefroy O. Functional consequences of a section of the anterior part of the body of the corpus callosum: evidence from an interhemispheric transcallosal approach. J Neurol. 2012; 259: 1860-7.

Bugnicourt JM, Chillon JM, Massy ZA, Leclercq C, Godefroy O. Intracranial artery calcification and outcome in patients with ischaemic stroke. Eur J Neurol. 2012;19:e67.

Bugnicourt JM, Godefroy O. Transient acute tetraparesis revealing bihemispheric cerebral infarcts. Intern Med J. 2012; 42: 595.

Roussel M, Dujardin K, Hénon H, Godefroy O. Is the frontal dysexecutive syndrome due to a working memory deficit? Evidence from patients with stroke. Brain 2012; 135: 2192-201.

Bugnicourt JM, Flament M, Guillaumont MP, Chillon JM, Leclercq C, Canaple S, Lamy C, Godefroy O. Predictors of newly diagnosed atrial fibrillation in cryptogenic stroke: a cohort study. Eur J Neurol 2012

Loas G, Krystkowiak P, Godefroy O. Anhedonia in Parkinson's disease: an overview. J Neuropsychiatry Clin Neurosci. 2012 Sep 1;24(4):444-51.

Montalan B, Lelard T, Godefroy O, Mouras H. Behavioral investigation of the influence of social categorization on empathy for pain: a minimal group paradigm study. Front Psychol. 2012;3:389.

Bugnicourt JM, Godefroy O. Day-7 or day-90 modified Rankin scale score: what is the best measure of outcome after thrombolysis in ischemic stroke? J Thromb Thrombolysis. 2012 Oct 2

2011

Bugnicourt JM, Roussel B, Garcia PY, Canaple S, Lamy C, Godefroy O. Aspirin non-responder status and early neurological deterioration: A prospective study. Clin Neurol Neurosurg. 2011; 113: 196-201

Picard C, Pasquier F, Martinaud O, Hannequin D, Godefroy O. Early onset dementia: characteristics in a large cohort from academic memory clinics. Alzheimer Dis Assoc Disord. 2011; 25: 203-05

Godefroy O, Fickl A, Roussel M, Auribault C, Bugnicourt JM, Lamy C, Canaple S, Petitnicolas G. Is the Montreal Cognitive Assessment superior to the Mini-Mental State Examination to detect post-stroke cognitive impairment? A study with neuropsychological evaluation. Stroke 2011; 42: 1712-16

El Sankari S, Gondry-Jouet C, Fichten A, Godefroy O, Serot JM, Deramond H, Meyer ME, Balédent O. Cerebrospinal fluid and blood flow in mild cognitive impairment and Alzheimer's disease: a differential diagnosis from idiopathic normal pressure hydrocephalus. Fluids Barriers CNS. 2011 17; 8: 12.

Bugnicourt JM, Garcia PY, Canaple S, Lamy C, Godefroy O. Central neuropathic pain after cerebral venous thrombosis is not so uncommon: an observational study. J Neurol. 2011; 258: 1150-6.

Serot JM, Peltier J, Fichten A, Ledeme N, Bourgeois AM, Jouanny P, Toussaint P, Legars D, Godefroy O, Mazière JC. Reduced CSF turnover and decreased ventricular Aβ42 levels are related. BMC Neurosci. 2011; 12: 42.

Bugnicourt JM, Da Silveira C, Bengrine A, Godefroy O, Baumbach GL, Sevestre H, Bode-Boeger SM, Kielstein JT, Massy ZA, Chillon JM. Chronic renal failure alters endothelial function in cerebral circulation in mice. Am J Physiol Heart Circ Physiol. 2011; 301:H1143-52.

Bugnicourt JM, Leclercq C, Chillon JM, Diouf M, Deramond H, Canaple S, Lamy C, Massy ZA, Godefroy O. Presence of intracranial artery calcification is associated with mortality and vascular events in patients with ischemic stroke after hospital discharge: a cohort study. Stroke. 2011; 42: 3447-53.

Flament M, Loas G, Godefroy O, Krystkowiak P. Suicide without depression after withdrawal of a dopamine agonist in a patient with Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2011 Fall;23(4):E32.

Loas G, Yon V, Monestès JL, Cuesta MJ. Test-retest reliability of the Frankfurt Complaint Questionnaire. Psychol Rep. 2011 Apr;108(2):503-6.

Leroy M, Loas G, Perez-Diaz F. Cloninger's temperament traits as predictors of clinical events after acute coronary syndrome: a three-year prospective study. Psychother Psychosom. 2011;80(2):125-6.

Loas G, Yon V, Maréchal V, Dècle P. Relationships between subjective or objective symptoms and mortality in schizophrenia: a prospective study on 310 schizophrenic patients with a median follow-up of 8.4 years. Psychiatry Res. 2011 Jan 30;185(1-2):49- 53.

Loas G, Cormier J, Perez-Diaz F. Dependent personality disorder and physical abuse. Psychiatry Res. 2011 Jan 30;185(1-2):167- 70.

Speranza M, Loas G, Guilbaud O, Corcos M. Are treatment options related to alexithymia in eating disorders? Results from a three-year naturalistic longitudinal study. Biomed Pharmacother. 2011 Dec;65(8):585-9.

Delval A, Bleuse S, Simonin C, Delliaux M, Rolland B, Destee A, Defebvre L, Krystkowiak P, Dujardin K. Are gait initiation parameters early markers of Huntington's disease in pre-manifest mutation carriers? Gait Posture. 2011 Jun;34(2):202-7.

Orth M; European Huntington's Disease Network, Handley OJ, Schwenke C, Dunnett S, Wild EJ, Tabrizi SJ, Landwehrmeyer GB. Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY. J Neurol Neurosurg Psychiatry. 2011 Dec;82(12):1409-12.

Ligot N, Krystkowiak P, Simonin C, Goldman S, Peigneux P, Van Naemen J, Monclus M, Lacroix SF, Devos D, Dujardin K, Delmaire C, Bardinet E, Delval A, Delliaux M, Defebvre L, Yelnik J, Blond S, Destée A, De Tiège X. External globus pallidus stimulation modulates brain connectivity in Huntington's disease. J Cereb Blood Flow Metab. 2011 Jan;31(1):41-6.

Mouras H. The motivated brain: insights from neuroimaging studies of human male sexual affiliation context. Open Neuroimag J. 2011;5:51-6.